Cloudbreak Pharma Inc. (HKG:2592)
Hong Kong · Delayed Price · Currency is HKD 1.190
+0.025 (2.15%)
Sep 9, 2026, 6:08 PM HKT
Cloudbreak Pharma Revenue
Cloudbreak Pharma had revenue of $44.00K USD in the half year ending June 30, 2026. This brings the company's revenue in the last twelve months to $269.00K, down -97.37% year-over-year. In the year 2025, Cloudbreak Pharma had annual revenue of $253.00K, down -97.52%.
Revenue (ttm)
$269.00K
Revenue Growth
-97.37%
P/S Ratio
476.43
Revenue / Employee
$4.41K
Employees
61
Market Cap
1.01B HKD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 253.00K | -9.96M | -97.52% |
| Dec 31, 2024 | 10.21M | 9.33M | 1,060.68% |
| Dec 31, 2023 | 880.00K | 409.00K | 86.84% |
| Dec 31, 2022 | 471.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.